Search Results - "Burman, C.-F."

Semiparametric Weighted Spline Regression (SWSR) in Confirmatory Clinical Trials with Time-Varying Placebo Effects.

Authors: Zhan, Tianyu Gu, Yihua

Source: Journal of Computational & Graphical Statistics; Jan-Mar2026, Vol. 35 Issue 1, p111-118, 8p

Rejoinder to discussions on "Optimal test procedures for multiple hypotheses controlling the familywise expected loss".

Authors: Maurer, Willi Bretz, Frank Xun, Xiaolei

Source: Biometrics; Dec2023, Vol. 79 Issue 4, p2811-2814, 4p

From Resistance to Redesign—The Emerging Logic of Hybrid Care in Treatment-Resistant Depression.

Authors: Mucci, Federico Gurrieri, Riccardo Bouanani, Siham et al.

Source: Brain Sciences (2076-3425). Jun2026, Vol. 16 Issue 6, p612. 21p.

Interpretable Optimization: Why and How We Should Explain Optimization Models.

Authors: Lumbreras, Sara Ciller, Pedro

Source: Applied Sciences (2076-3417); May2025, Vol. 15 Issue 10, p5732, 28p

Comment on "Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials" by the Cross-Pharma Non-Proportional Hazards Working Group.

Authors: Lin, Ray S. Mukhopadhyay, Pralay Roychoudhury, Satrajit et al.

Source: Statistics in Biopharmaceutical Research. Apr-Jun2023, Vol. 15 Issue 2, p312-314. 3p.

Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion.

Authors: Sridhara, Rajeshwari Marchenko, Olga Jiang, Qi et al.

Source: Statistics in Biopharmaceutical Research. Jul-Sep2022, Vol. 14 Issue 3, p353-357. 5p.

Changing interim monitoring in response to internal clinical trial data.

Authors: Proschan, Michael A. Nason, Martha Ortega-Villa, Ana M. et al.

Source: Biometrics; Mar2024, Vol. 80 Issue 1, p1-9, 9p, 1 Diagram, 2 Graphs

Treatment-Control Comparisons in Platform Trials Including Non-Concurrent Controls.

Authors: Bofill Roig, Marta Krotka, Pavla Hees, Katharina et al.

Source: Statistics in Biopharmaceutical Research. Jan-Mar2026, Vol. 18 Issue 1, p79-96. 18p.

Use of Common Control Arms Across Substudies in a Master Protocol via Ridge Estimation.

Authors: Nimura, Akinori Sato, Tosiya

Source: Statistics in Biopharmaceutical Research. Jan-Mar2026, Vol. 18 Issue 1, p175-186. 12p.

Improved Trimmed Weighted Hochberg Procedures With Two Endpoints and Sample Size Optimization.

Authors: Gou, Jiangtao Chang, Yizhuo Li, Tianqi et al.

Source: Statistics in Biopharmaceutical Research. Jan-Mar2026, Vol. 18 Issue 1, p117-128. 12p.

Distribution Analysis of the Lifespan Trait in Drosophila.

Authors: Yumuhova, Camila A. Konopatov, Alexander V. Shtil, Alexander A. et al.

Source: International Journal of Molecular Sciences. Dec2025, Vol. 26 Issue 24, p11987. 33p.

Optimal test procedures for multiple hypotheses controlling the familywise expected loss.

Authors: Maurer, Willi Bretz, Frank Xun, Xiaolei

Source: Biometrics; Dec2023, Vol. 79 Issue 4, p2781-2793, 13p

Towards high-quality and timely interim analyses in adaptive trials: a scoping review of best practice and evidence gaps.

Authors: Thomson KH Agbeleye O Oparah C et al.

Source: Trials [Trials] 2026 Mar 21; Vol. 27 (1). Date of Electronic Publication: 2026 Mar 21.

Publication Type: Journal Article; Scoping Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Group Sequential Design for Non-Proportional Hazards: Logrank, Weighted Logrank, and MaxCombo Methods.

Authors: Zhao, Yujie Zhang, Yilong Leon, Larry et al.

Source: Statistics in Biopharmaceutical Research. Oct2025, p1-10. 10p. 3 Illustrations.

A practical guide to simulation for an adaptive trial design with a single interim analysis.

Authors: Jayawardana, Kaushala S. Dymock, Michael Mahar, Robert K. et al.

Source: Trials. 10/9/2025, Vol. 26 Issue 1, p1-20. 20p.

Random Effects Meta-Analysis of Contingency Tables with Complete and Partially Complete Data, with Application to COVID-19 Research.

Authors: Racine-Poon, Amy Praestgaard, Jens Sverdlov, Oleksandr

Source: Statistics in Biopharmaceutical Research. Oct-Dec2025, Vol. 17 Issue 4, p548-556. 9p.

Rejoinder to Comments on "Non-Proportional Hazards – An Evaluation of the MaxCombo Test in Cancer Clinical Trials".

Authors: Shen, Yuan-Li Mushti, Sirisha Mulkey, Flora et al.

Source: Statistics in Biopharmaceutical Research. Apr-Jun2023, Vol. 15 Issue 2, p315-317. 3p.

Covariate-Adjusted Response Adaptive Designs for Competing Risk Survival Models.

Authors: Mukherjee, Ayon Sayantee, Jana

Source: Statistics in Biopharmaceutical Research. Jul-Sep2025, Vol. 17 Issue 3, p323-346. 24p.

Two-Stage Adaptive Enrichment Designs with Survival Outcomes and Adjustment for Misclassification in Predictive Biomarkers.

Authors: Chen, Yanping Lin, Yong Lu, Shou-En et al.

Source: Statistics in Biopharmaceutical Research. Jul-Sep2025, Vol. 17 Issue 3, p425-445. 21p.

Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials.

Authors: Geroldinger, Martin Verbeeck, Johan Hooker, Andrew C. et al.

Source: Orphanet Journal of Rare Diseases. 12/19/2023, Vol. 18 Issue 1, p1-12. 12p.